47
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Pathogenesis I: interactions of host cells and fungi

, , , , , , , , , , , , , , , , , & show all
Pages 99-111 | Published online: 01 Apr 2010

References

  • Burger E, Miyaji M, Sano A, Calich VLG, Nishimura K, Miyaji M. Paracoccidioides brasiliensis infection in nude mice: studies with isolates differing in virulence and definition of their T-dependent and T-independent components. Am J Trop Med Hyg 1966; 55: 391–398.
  • Restrepo A, Vélez H. Effects de la fagocitosis 'in vitro' sobre Paracoccidioides brasiliensis. Sabouraudia 1975; 13: 10–21.
  • Goihman-Yahr M, Essenfeld-Yahr E, Albornoz M, et al. De-fect of in vitro digestive ability of polymorphonuclear leuko-cytes in paracoccidioidomycosis. Infect unman 1980; 28: 557–566.
  • McEwen JG, Brummer E, Stevens DA, Restrepo A. Effect of murine polymorphonuclear leukocytes on the yeast form of Paracoccidioides brasiliensis. Am J Trop Med Hyg 1987; 36: 603–608.
  • McEwen JG, Sugar AM, Brummer E, Restrepo A, Stevens DA. Toxic effect of products of oxidative metabolism on the yeast form of P. brasiliensis. J Med Microbiol 1984; 18: 423–428.
  • Kurita N, Biswas SK, Oarada M, Sano A, Nishimura K, Miyaji M. Fungistatic and fungicidal activities of murine poly-morphonuclear leucocytes against yeast cells of Paracoccid-ioides brasiliensis. Med Mycol 1999; 37: 19–24.
  • Meloni-Bruneri LH, Campa A, Abdalla DSP, Calich VLG, Lenzi HL, Burger E. Neutrophil oxidative metabolism and killing of Paracoccidioides brasiliensis after air pouch infection of susceptible and resistant mice. J Leukoc Biol 1996; 59: 526–533.
  • Xidieh CF, Lenzi HL, Calich VLG, Burger E. Influence of the genetic background in the pattern of lesions developed by resistant and susceptible mice infected with Paracoccidioides brasiliensis. Med Microbiol Immunol 1999; 188: 41–49.
  • Fernandes-Bordignon GF, Burger E. Fungicidal activity in vivo of polymorphonuclear neutrophils in air pouch of isogenic mice on Paracoccidioides brasiliensis yeasts. Proceedings of IX Inter-national Congress of Mycology, Sydney, August 12–20, 1999. International Union of Mycological Societies, 1999: Abstract MP3.42.
  • Campa A, Meloni-Bruneri LH, Burger E. Oxidative burst and membrane neutral lipids in polymorphonuclear leukocytes. Proceedings of Congresso da Sociedade Brasileiro de Bioquimica, Caxambii, 1999: Abstract P13.
  • Burger E, Fernandes-Bordignon GF. Concentration of chemo-tactic and attractant factors to polymorphonuclear neutrophils in air pouch of susceptible and resistant mice to Paracoccid-ioides brasiliensis. Proceedings of IX International Congress of Mycology, Sydney, August 12–20, 1999. International Union of Mycological Societies, 1999: MP3.41.
  • Meloni-Bruneri LH, Burger E, Camilo C, Xidieh CF, Arruda C, Calich VLG. Effect of PMN depletion on the course of Paracoccidioides brasiliensis infection of athymic and euthymic mice. Proceedings of IX International Congress of Mycology, Sydney, August 12–20, 1999. International Union of Mycolog-ical Societies, 1999: MP3.44.
  • Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999; 29: 239–244.
  • Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med 1988; 148: 2642–2645.
  • Edwards Jr JE, Mayer CL, Filler SG, Wadsworth E, Calderone RA. Cell extracts of Candida albicans block adherence of the organisms to endothelial cells. Infect Immun 1992; 60: 3087–3091.
  • Klotz SA. Fungal adherence to the vascular compartment: a critical step in the pathogenesis of disseminated candidiasis. Clin Infect Dis 1992; 14: 340–347.
  • Rotrosen D, Edwards Jr JE, Gibson TR, Moore JC, Cohen AH, Green I. Adherence of Candida to cultured vascular en-dothelial cells: mechanisms of attachment and endothelial cell penetration. J Infect Dis 1985; 152: 1264–1274.
  • Filler SG, lbe BO, Luckett PM, Raj JU, Edwards Jr JE. Candida albicans stimulates endothelial cell eicosanoid produc-tion. J Infect Dis 1991; 164: 928–935.
  • Filler SG, Swerdloff JN, Hobbs C, Luckett PM. Penetration and damage of endothelial cells by Candida albicans. Infect Immun 1995; 63: 976–983.
  • Fratti RA, Belanger PH, Ghannoum MA, Edwards Jr JE, Filler SG. Endothelial cell injury caused by Candida albicans is dependent on iron. Infect Immun 1998; 66: 191–196.
  • Fratti RA, Ghannoum MA, Edwards Jr JE, Filler SG. Gamma interferon protects endothelial cells from damage by Candida albicans by inhibiting endothelial cell phagocytosis. Infect Im-mun 1996; 64: 4714–4718.
  • Klotz SA, Maca RD. Endothelial cell contraction increases Candida adherence to exposed extracellular matrix. Infect Im-mun 1988; 56: 2495–2498.
  • Filler SG, Plunder AS, Spellberg BJ, Spellberg JP, Edwards Jr JE. Candida albicans stimulates cytokine production and leuko-cyte adhesion molecule expression by endothelial cells. Infect Immun 1996; 64: 2609–2617.
  • Orozco AS, Thou X, Filler SG. Mechanisms of the pro-inflam-matory response of endothelial cells to Candida albicans infec-tion. Infect Immun 2000; 68: 1134–1141.
  • Fu Y, Rieg G, Fonzi WA, Belanger PH, Edwards Jr JE, Filler SG. Expression of the Candida albicans gene ALS1 in Saccha-romyces cerevisiae induces adherence to endothelial and epithe-lial cells. Infect Immun 1998; 66: 1783-1786.
  • Hoyer LL, Scherer S, Shatzman AR, Livi GP. Candida albicans ALS1: domains related to a Saccharomyces cerevisiae sexual agglutinin separated by a repeating motif. Mol Microbiol 1995; 15: 39–54.
  • Lipke PN, Wojciechowicz D, Kurjan J. AG alpha 1 is the structural gene for the Saccharomyces cerevisiae alpha-agglu-tinin, a cell surface glycoprotein involved in cell-cell interac-tions during mating. Mol Cell Biol 1989; 9: 3155–3165.
  • Wojciechowicz D, Lu CF, Kurjan J, Lipke PN. Cell surface anchorage and ligand-binding domains of the Saccharomyces cerevisiae cell adhesion protein alpha-agglutinin, a member of the immunoglobulin superfamily. Mol Cell Biol 1993; 13: 2554–2563.
  • Phan QT, Belanger PH, Filler SG. Role of hyphal formation in interactions of Candida albicans with endothelial cells. Infect Immun 2000; 68: 3485–3490.
  • Edwards Jr JE, Rotrosen D, Fontaine JW, Haudenschild CC, Diamond RD. Neutrophil-mediated protection of cultured hu-man vascular endothelial cells from damage by growing Can-dida albicans hyphae. Blood 1987; 69: 1450–1457.
  • Denning DW, Follansbee SE, Scolaro M, Norris S, Edelstein H, Stevens DA. Pulmonary aspergillosis in the acquired im-munodeficiency syndrome. New Engl J Med 1991; 324: 652–654.
  • Khoo SH, Denning DW. Invasive aspergillosis in patients with AIDS. Clin Infect Dis 1994; 19 (Suppl 1): 41–48.
  • Minamoto GY, Barlam TF, Vander Els NJ. Invasive aspergillo-sis in patients with AIDS. Clin Infect Dis 1992; 14: 66–74.
  • Wingard JR, Beals SU, Santos G, Merz WG, Saral R Asper-gillus infections in bone marrow transplant recipients. Bone Marrow Transplan 1987; 2: 175–181.
  • Miller WT, Sais GJ, Frank I, Gefter WB, Aronchick JM, Miller WT. Pulmonary aspergillosis in patients with ADS. Chest 1994; 105: 37–44.
  • Lortholary O, Meyohas MC, Dupont B, et al. Invasive asper-gillosis in patients with Acquired Immunodeficiency Syndrome: Report of 33 cases. Am J Med 1993; 95: 177–187.
  • Karam GH, Griffin FM. Invasive pulmonary aspergillosis in nonimmunocompromised, nonneutropenic hosts. Rev Infect Dis 1986; 8: 357–363.
  • Shaffner A, Douglas HAB. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. J Clin Invest 1982; 69: 617–631.
  • Williams DM, Drutz DJ. Immunologic studies of disseminated infection with Aspergillus fumigatus in the nude mouse. J Infect Dis 1981; 143: 726–733.
  • Cenci WE, Perito S, Enssle K-H, et al. Thl and Th2 cytokines in mice with invasive aspergillosis. Infect Immun 1997; 65: 564–570.
  • Cohen DM, Savary CA, Martins MD, et al. Binding of lymphocytes to Aspergillus fumigatus conidia: Inhibition by antibodies to mammalian adhesion molecules. 33rd Annual Meeting of Infectious Diseases Society of America, San Fran-cisco, CA, September 1995. Alexandria, VA: Infectious Dis-eases Society of America, 1995: Abstract 519.
  • Martins MD, Rodriguez LJ, Savary CA, et al. Activated lymphocytes reduce adherence of Aspergillus fumigatus. Med Mycol 1998; 36: 281–289.
  • Grazziutti ML, Rex JH, Cowart RE, Anaissie EJ, Ford A, Savary CA. Aspergillus fumigatus conidia induce a Thl-type cytokine response. J Infect Dis 1997; 176: 1579–1583.
  • Roilides E, Uhlig K, Venzon D, Pizzo PA, Walsh TJ. Enhance-ment of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte-colony stimulatory factor and gamma-interferon. Infect Immun 1993; 61: 1185–1193.
  • Roilides E, Uhling K, Venzon D, Pizzo PA, Walsh TJ. Preven-tion of corticosteroid-induced suppression of human polymor-phonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma-interferon. Infect Immun 1993; 61: 4870–4877.
  • Roilides E, Holmes A, Blake C, Venzon D, Pizzo PA, Walsh TJ. Antifungal activity of elutriated human monocyte against Aspergillus fumigatus hyphae: enhancement by granulocyte macrophage colony-stimulating factor and gamma-interferon. J Infect Dis 1994; 170: 894–899.
  • Nagai H, Gou J, Hongyung C, Kurup V. Interferon-gamma and tumor necrosis factor-alpha protect mice from invasive aspergillosis. J Infect Dis 1995; 172: 1554–1560.
  • Steinman RM. The dendritic cell system and its role in im-munogenicity. Ann Rev Immunol 1991; 9: 271–296.
  • Hart DNJ. Dendritic cells: Unique leukocyte populations which control the primary immune response. Blood 1997; 90: 3245–3287.
  • Van Voorhis WC, Valinsky J, Hoffman E, Luban J, Hair LS. Relative efficacy of human monocytes and dendritic cells as accessory cells. J Exp Med 1983; 158: 174–192.
  • Savary CA, Grazziutti ML, Przepiorka D, Braunschweig I, Rex JH. Dendritic cell response to pathogenic fungi. Keystone Sym-posia: Cellular and Molecular Biology of Dendritic Cells, Santa Fe, New Mexico, 1998: 98.
  • Roilides E, Kadiltsoglou I, Sein T, Walsh T. Interleukin-12 enhances antifungal activity of human mononuclear phagocytes against Aspergillus fumigatus: implications for a gamma inter-feron-independent pathway. Infect Immun 1999; 67: 3047–3050.
  • Grazziutti ML, Savary CA, Przepiorka D, Cowart RE, Rex JH. Comparison of the efficiency of monocytes and dendritic cells as stimulators of lymphocyte proliferative response to Asper-gillus fumigatus and Candida albicans. 35th Annual Meeting of Infectious Disease Society of America, San Francisco, CA, September 13–16, 1997. Alexandria, VA: Infectious Diseases Society of America, 1997: Abstract 123.
  • Savary CA, Grazziutti ML, Melichar B, et al. Multidimensional flow cytometric analysis of dendritic cells in peripheral blood of normal donors and cancer patients. Cancer Immunol Im-munother 1998; 45: 234–240.
  • Parkman R, Weinberg KI. Immunological reconstitution fol-lowing bone marrow transplantation. Immunol Rev 1997; 157: 73–78.
  • Grazziutti ML, Savary CA, Przepiorka D, Vadham-Raj S, Braunschwey I, Rex JH. In vitro reconstitution of lymphocyte proliferative response against fungal antigens one month after peripheral blood stem cell transplantation (PBSCT) by addition of dendritic cells. 36th Annual Meeting of Infectious Disease Society of America, Denver, CO, November 12–15, 1998. Alex-andria, VA, Infectious Diseases Society of America, 1998: Abstract 339.
  • Gordon MA, Vedder DK. Serologic tests in diagnosis and prognosis of cryptococcosis. J Am Med Assoc 1966; 197: 961–967.
  • Baker RD, Haugen RK. Tissue changes and tissue diagnosis in cryptococcosis. A study of twenty-six cases. Am J Gun Pathol 1955; 25: 14–24.
  • Farmer SG, Komoromski RA. Histologic response to capsule-deficient Cryptococcus neoformans. Arch Pathol 1973; 96: 383–387.
  • Diamond RD, Bennett JE. Prognostic factors in cryptococcal meningitis. A study in 111 cases. Ann Intern Med 1974; 80: 176–181.
  • Murphy JW. Cell-mediated immunity. In: Howard DH, Miller JD, eds. The Mycota VI Human and Animal Relationships. Berlin: Springer-Verlag, 1996: 67–97.
  • Casadevall A, Perfect JR. Cryptococcus neoformans. Washing-ton DC: ASM Press, 1998.
  • Murphy JW. Cell-mediated immunity and medically related fungi. In: Cunningham MW, Fujinami RS, eds. Effects of Microbes on the Immune System. Philadelphia: Lippincott Williams & Wilkins, 1999: 593–621.
  • Murphy JW. Clearance of Cryptococcus neoformans from im-munologically suppressed mice. Infect Immun 1989; 57: 1946–1952.
  • Dong ZM, Murphy JW. Mobility of human neutrophils in response to Cryptococcus neoformans cells, culture filtrate anti-gen, and individual components of the antigen. Infect Immun 1993; 61: 5067–5077.
  • Dong ZM, Murphy JW. Effects of two varieties of Cryptococ-cus neoformans cells and culture filtrate antigens on neutrophil locomotion. Infect Immun 1995; 63: 2632–2644.
  • Dong ZM, Murphy JW. Intravascular cryptococcal culture filtrate (CneF) and its major component glucuronoxylomannan (GXM) are potent inhibitors of leukocyte accumulation. Infect Immun 1995; 63: 770–778.
  • Dong ZM, Murphy JW. Cryptococcal polysaccharides induce L-selectin shedding and tumor necrosis factor receptor loss from the surface of human neutrophils. J Clin Invest 1996; 97: 689–698.
  • Murphy JW. Immunological down-regulation of host defenses in fungal infections. Mycoses 1999; 42 (Suppl 2): 37–43.
  • Roilides E, Kadiltsoglou I, Dimitriadou A, et al. Interleukin-4 suppresses antifungal activity of human mononuclear phago-cytes against Candida albicans in association with decreased uptake of blastoconidia. FEMS Immunol Med Microbiol 1997; 19: 169–180.
  • Roilides E, Dimitriadou A, Kadiltsoglou I, et al. Effects of interleukin-4 on antifungal activity of mononuclear phagocytes against hyphae and conidia of Aspergillus fumigatus. 7th Eu-ropean Congress of Clinical Microbiology and Infectious Dis-eases, Vienna Austria, March 1995. Tubingen, Germany: European Society of Clinical Microbiology and Infectious Dis-eases, 1995: Abstract 999.
  • Roilides E, Dimitriadou A, Kadiltsoglou I, et al. IL-10 exerts suppressive and enhancing effects on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J Im-munol 1997; 158: 322–329.
  • Roilides E, Katsifa H, Tsaparidou S, et al. Interleukin-10 suppresses phagocytic and antihyphal activities of human neu-trophils. Cytokine 2000; 12: 379–387.
  • D'Andrea A, Ma X, Aste-Amezaga M, Paganin C, Trinchieri G. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha production. J Exp Med 1995; 181: 537–546.
  • Katsifa H, Roilides E, Tsaparidou S, et al. Effects of inter-leukin-13 on antifungal activity of human monocytes against Candida albicans. Program and Abstracts of the 10th Interna-tional Symposium on Infections in the Immunocompromised Host, Davos Switzerland, June 1998. Dacula, GA: International Immunocompromised Host Society, 1998: Abstract 125.
  • Roilides E, Dimitriadou A, Kadiltsoglou I, Pizzo PA, Walsh TJ. Lack of effects of transforming growth factor 131 (TGFI3) on antifungal activity of mononuclear phagocytes against conidia and hyphae of Aspergillus fumigatus in vitro. Program and Abstracts of the 35th Interscience Conference Antimicrob. Agents Chemother, San Francisco, CA, September 1995. Wash-ington DC: American Society for Microbiology, 1995: Abstract G98.
  • Roilides E, Dimitriadou A, Kadiltsoglou I, Anastasiou A, Walsh TJ. Effects of transforming growth factor-I31 (TGFI3) in combination with other immunomodulators on antifungal ac-tivity of human monocytes (MN C) against Aspergillus fumiga-tus. Program and Abstracts of the 9th International Symposium on Infections in the Immunocompromised Host. Assisi Italy, June 1996. Dacula, GA: International Immunocompromised Host Society, 1996: Abstract 191.
  • Cenci E, Mencacci A, Fè d'Ostiani C, et al. Cytokine- and T helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis. J Infect Dis 1998; 178: 1750–1760.
  • Cenci E, Mencacci A, Del Sero G, et al. Interleukin-4 causes susceptibility to invasive aspergillosis through suppression of protective type 1 responses. J Infect Dis 1999; 180: 1957-1968.
  • Roilides E, Holmes A, Blake C, Pizzo PA, Walsh TJ. Impair-ment of neutrophil fungicidal activity in HIV-infected children against Aspergillus fumigatus hyphae. J Infect Dis 1993; 167: 905–911.
  • Roilides E, Holmes A, Blake C, Pizzo PA, Walsh TJ. Defective antifungal activity of monocyte-derived macrophages from HIV-infected children against Aspergillus fumigatus. J Infect Dis 1993; 168: 1562–1565.
  • Clerici M, Wynn TA, Berzofsky JA, et al. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J Clin Invest 1994; 93: 768–775.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.